The purpose of this study was to examine whether the degree of sensitivity to nondepolarizing muscle relaxants is related to the requirement for postoperative ventilatory support in patients with myasthenia gravis.
Patients with myasthenia gravis undergoing thymectomy sometimes require prolonged postoperative ventilation. Up to 50% of patients undergoing thymectomy for myasthenia gravis required prolonged postoperative ventilation 1. Several reports have investigated predictors of the need for postoperative ventilatory support in patients with myas-thenia gravis [1] [2] [3] [4] . Leventhal and co-workers 2 identified four such risk factors : duration of myasthenia gravis 6 years or more, the presence of chronic respiratory disease, pyridostigmine dosage 750 mg per day or greater and a vital capacity of 2.9 l or less.
Myasthenia gravis is associated with a reduction in the number of functional acetylcholine receptors at the post-synaptic neuromuscular junction, and this reduction is due to inactivation or destruction of the receptors by circulating anti-acetylcholine receptor antibodies. This may explain the marked sensitivity of these patients to nondepolarizing muscle relaxants such as vecuronium 5 . Nilsson et al 5 reported that the average ED95 value of vecuronium was 250% greater in controls than in myasthenic patients. We hypothesized that this increased sensitivity to nondepolarizing muscle relaxants could be associated with an increased need for postoperative ventilation in patients with myasthenia gravis.
In this study, we examined whether the degree of sensitivity to nondepolarizing muscle relaxants is related to the requirement for postoperative ventilation in patients with myasthenia gravis.
METHODS
From 1998 to 2002, 36 patients with myasthenia gravis undergoing trans-sternal thymectomy were studied. None of the patients showed evidence of cardiac, renal, or hepatic disease. The diagnosis of myasthenia gravis was confirmed by a typical case history, characteristic neurophysiologic findings obtained from the evoked compound electromyogram (EMG), the presence of acetylcholine receptor (anti-AChR) antibodies and/or a positive response to edrophonium. Acetylcholine receptor antibodies were determined by a radioimmunoassay method. Titres are expressed as arbitrary units/litre. Titres of 0.04 are considered abnormal. A previous episode of respiratory failure due to myasthenia gravis that required mechanical ventilatory support was considered as a history of respiratory crisis.
The clinical severity of myasthenia gravis was assessed using Osserman's classification 6 : class 1 myasthenia gravis is characterized by ocular involvement only; class 2A is generalized muscular involvement but without respiratory impairment; class 2B has more bulbar manifestations than class 2A. Class 3 includes rapid onset and progression of bulbar and generalized disease with respiratory muscle weakness, and the incidence of thymoma is high and there is significant mortality. In class 4, progressive myasthenia gravis symptoms develop in patients who had previously experienced symptoms of class 1 or class 2 for at least two years, and there is a high incidence of thymoma, the response to drug therapy is poor, and the prognosis is very poor.
All of the myasthenic patients were being treated with pyridostigmine. Anticholinesterase medication was withdrawn 12 hours preoperatively.
This study had the approval of the ethics committee of our institution and written informed consent was obtained from all patients.
All patients received atropine sulfate (0.01 mg/kg) IM 60 min before induction of anaesthesia. Anaesthesia was induced with fentanyl 2 microgram/kg and propofol 2 mg/kg. After induction, all patients were ventilated with a mixture of 34% oxygen and 66% nitrous oxide. End-tidal carbon dioxide was monitored (UltimaR, Datex, Helsinki, Finland) and maintained within the normal range. P a O 2 was maintained at 150 to 300 mmHg during the study. Ventilation was controlled with a facemask.
Neuromuscular transmission was monitored by electromyography (EMG; Datex, instrumentation Co., Helsinki Finland). The ulnar nerve was stimulated supramaximally at the wrist every 20 seconds, and the resulting electromyographic response was displayed. The monitor used the train-of-four principle, at a stimulation rate of 2 Hz, and featured an automatic search for the supramaximal stimulus. The ratio of the fourth to the first evoked response (T4/T1 ratio) was automatically computed by the monitor. Stimulation and recordings were made via surface electrodes. After calibration of baseline EMG response values to 100% by the EMG monitor, vecuronium was administered in incremental doses of 5, 10 and 20 µg/kg body weight to produce a 95% neuromuscular blockade and to obtain a cumulative dose-response curve for each patient. The cumulative doses were thus 5, 10, 20 and 40 µg/kg. The electromyographic response was observed for a maximal effect after each dose before the next incremental dose was given. Each patient received between three and seven incremental doses of vecuronium and the total duration of the study in each patient was between 10 and 15 minutes. Following completion of the dose-response study, the trachea was intubated. Anaesthesia and muscular relaxation were maintained with nitrous oxide and sevoflurane. Subsequent doses of vecuronium (one fifth of individual ED95 doses) were given when the EMG T4/T1 ratio exceeded 25%. At the end of surgery, all patients received 0.05 mg/kg of neostigmine and 0.02 mg/kg of atropine. All patients were transferred to the Intensive Care Unit (ICU) with an EMG monitor.
On arrival in the ICU, respiratory status was assessed. Tracheal extubation was performed when clinical and respiratory variables were judged to be adequate. Extubation criteria were: 1. adequate recovery from neuromuscular function (T4/T1 70% or greater as assessed by EMG 6 ), 2. tidal volume greater than 5 ml/kg during unassisted spontaneous breathing and 3. maximum inspiratory pressure of more than -20 cm H 2 O. There were no operative or hospital deaths and no phrenic or recurrent laryngeal nerve injuries in this patient population.
After completion of the study, patients were questioned about their awareness during the measurement of the degree of neuromuscular blockade, and it was found that none of the patients was aware during the study.
According to the Naguib et al criteria 1 , the patients were divided into two groups: 1. those patients who were extubated shortly (<6 hours) after admission to the ICU (Group 1), and 2. those patients who were Anaesthesia and Intensive Care, Vol. 32, No. 3, June 2004 extubated more than six hours after admission to the ICU (Group 2).
Statistical analysis
All data was expressed as mean±SD. The data was examined for normal distribution of variance by the Bartlett test, and an unpaired t-test, Fisher's exact test or Scheff's test was used for analysis between groups.
A univariable logistic regression with odds ratio was used to determine the predictive variables of postoperative prolonged ventilation.
Statistical significance was set at P<0.05. All calculations were performed on a Macintosh computer with Stat View 5.0 software packages (Abacus Concepts, Inc, Berkeley, CA) and Stat Mate III (Atoms, Co, Tokyo, Japan).
RESULTS
There were no significant differences in demographic data such as age, height and weight between the two groups. Table 1 shows the demographic data of the two groups. Twenty-one patients were successfully extubated in the immediate postoperative period (Group 1). Of the patients in this group, eleven were extubated immediately upon arrival at the ICU, while the ten remaining patients were extubated one to five hours later. Group 2 consisted of 15 patients who needed ventilatory support for at least six hours (three patients required ventilatory support for six hours, two patients for seven hours, two patients for eight hours, one patient for nine hours, one patient for 14 hours, one patient for 17 hours, one patient for 21 hours, one patient for 22 hours, one patient for 24 hours, one patient for 38 hours, and one patient for 110 hours). None of the patients had postoperative respiratory complications, such as pneumonia, or needed reintubation to correct hypoxaemia.
There were no significant differences between the two groups in terms of vecuronium ED95 (prolonged group: 23.2±18 µg/kg; early group: 23.2±18 µg/kg, P=0.129) and the amount of vecuronium required to maintain the neuromuscular blockade at less than 25% (prolonged group: 2.4±1.7 mg/kg; early group: 3.8±4.5 mg/kg, P=0.249) There were, however, significant differences in the incidence of a history of previous respiratory crisis and the presence of bulbar palsy between the two groups. A previous history of respiratory crisis (odds ratio (OR), 3.5; 95% confidence interval (CI), 1.0-13; P=0.03) and the presence of bulbar palsy (OR, 3.7; 95%CI, 0.9-15; P=0.049) were associated with the requirement for prolonged postoperative ventilation (Table 2 ).
There were no significant differences in anti-acetyl-choline receptor antibody levels, vecuronium ED95s or extubation times between the two groups ( Table 3) . Anti-acetylcholine receptor antibody levels had significant correlation with individual ED95s of vecuronium (ED95=33.731.10 -0.005 X , r=0.658, P=0.0008, Figure 1 ). However, the duration of myasthenia gravis (P=0.13), the grade of the disease (P=0.69), and preoperative pyridostigmine dosages (P=0.12) had no correlation with the neuromuscular sensitivity to vecuronium.
DISCUSSION
In this study, we examined the effects of perioperative factors on the requirement for prolonged postoperative ventilation in patients with myasthenia gravis, and found that a history of previous respira- tory crisis and the presence of bulbar palsy were the main indicators of the need for prolonged postoperative ventilation. We failed to demonstrate any correlation between the degree of sensitivity to nondepolarizing muscle relaxants and the requirement for postoperative ventilation in patients with myasthenia gravis. There have been many reports examining the predictors of postoperative prolonged ventilation in these patients [1] [2] [3] [4] . Leventhal and co-workers 2 used discriminant analysis to evaluate their experiences with 24 patients who had undergone thymectomy for the treatment of myasthenia gravis. They found four risk factors that showed significant correlation with the need for postoperative ventilatory support: 1. duration of symptoms of myasthenia gravis of more than six years, 2. history of other chronic respiratory disease, 3. preoperative (48 hours) dosage of pyridostigmine more than 750 mg/day, and 4. preoperative vital capacity less than 2.9 l. Naguib and colleagues 1 reported that they identified seven variables; (forced vital capacity (FVC), forced expiratory volume (FEV) 25-75%, and maximum expiratory volume (MEV) 50%; and their percentages of the predicted values, gender) that predicted respiratory outcome in post-thymectomy patients. In addition, they found the risk factors previously identified by Leventhal to be unimportant in their study. Our results were inconsistent with those of Leventhal 2 and Naguib 1 . This discrepancy could be attributed to several reasons.
One third of our patients were classified as Osserman's class 1, which is characterized by ocular involvement only. In contrast, 21 of 51 patients in the Naguib study were classified as Osserman's class 3. Naguib 1 could not identify the presence of bulbar palsy in seven patients classified as Osserman's class 1.
The preoperative dosage of pyridostigmine reported in Leventhal's study ranged from none to 1290 mg/day, compared with 10 to 600 mg/day in our study. In addition, only one patient in our study had significantly impaired pulmonary function (less than 70% of the predicted values for FVC or FEV1). Another important factor that should be considered is that the anaesthetic regimen may have some influence on our results. It is generally recognized in patients with myasthenia gravis that there is a reduction in the number of acetylcholine receptors at the neuromuscular junction and, hence, a reduction of the safety margin. This makes myasthenic patients sensitive to nondepolarizing neuromuscular blocking agents. Neuromuscular blocking agents were not used Data are expressed as mean±SD. There were no significant differences between groups (Scheff's test). To examine the vecuronium ED95 dose, nondepolarizing neuromuscular blocking agents were used for all patients in our study. In this study, we used sevoflurane as an anesthetic agent. It is possible that volatile anesthetics may be associated with a slow recovery and postoperative respiratory depression 8 . It is reported that myasthenic patients are more sensitive than normal to the neuromuscular depressant effects of halothane and isoflurane 8 . In addition, Itoh and co-workers 9 showed that sevoflurane had a more marked effect than propofol on neuromuscular function, and suggested that residual neuromuscular blockade would be more frequent during sevoflurane anaesthesia than during propofol anaesthesia.
There have been many reports studying the effects of nondepolarizing neuromuscular blocking agents on myasthenic patients. Nilsson and colleagues 5 examined the vecuronium ED95 in 11 myasthenic patients, and found that the average ED95 value was 250% greater in control than in myasthenic patients. Eisenkraft and colleagues 10 reported the same phenomenon. Itoh and colleagues 11, 12 reported that although there was no significant difference in sensitivity to vecuronium in seropostive and seronegative patients with myasthenia gravis, marked difference in sensitivity to vecuronium was found between patients with ocular and generalized myasthenia gravis. Our results, showing that no significant differences in vecuronium ED95 were observed between the different classes according to Osserman's classification, were inconsistent with those of Itoh. The discrepancy might be attributable to the absence of volatile anesthetic agents in our study. We did not examine vecuronium ED95 under volatile anaesthesia. In contrast, Itoh 12 examined vecuronium ED95 under 2.5 MAC sevoflurane anaesthesia. It is generally known that volatile anaesthetic agents decrease the availability of acetylcholine at the neuromuscular junction and increase the neuromuscular block produced by non-depolarizing neuromuscular blocking agents 13 .
Our study demonstrated that a carefully taken history of previous respiratory crises or of bulbar symptomatology would be a better determinant of the need for prolonged postoperative ventilation (greater than six hours following surgery) than would complex testing or laboratory values.
In conclusion, we examined the effects of perioperative factors on postoperative prolonged ventilation in patients with myasthenia gravis and found that a history of previous respiratory crisis and presence of bulbar palsy were important factors in determination of the need for prolonged postoperative ventilation.
